Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Merck Covid antiviral pill did not cut hospitalization risk, study finds
Financial Times
Sun, 10/9/22 - 06:08 pm
Merck
COVID-19
molnupiravir
From Africa to Australia and beyond, BioNTech's global mRNA ambitions take flight
Fierce Pharma
Fri, 10/7/22 - 10:49 am
Pfizer
BioNTech
MRNA
Australia
COVID-19
FDA nixes EUA ambitions for Eiger's COVID treatment, proposes full approval pathway instead
Fierce Biotech
Thu, 10/6/22 - 10:52 am
Eiger BioPharmaceuticals
FDA
COVID-19
peginterferon lambda
AstraZeneca's Evusheld loses potency against new omicron subvariant, FDA warns
Fierce Pharma
Wed, 10/5/22 - 10:37 am
AstraZeneca
COVID-19
Omicron BA.4.6
Evusheld
In post-Covid life, Vir looks to stomp out influenza in up to $1B BARDA contract that boosts GSK-allied mAb
Endpoints
Tue, 10/4/22 - 10:45 am
Vir Biotechnology
COVID-19
Flu
BARDA
federal contracts
Ocugen sniffs out COVID-19 vaccine opportunity, landing rights to nasal candidate with India authorization
Fierce Pharma
Tue, 10/4/22 - 10:42 am
Ocugen
vaccines
COVID-19
intranasal vaccines
Europe
Japan
India
Amid scrutiny around Europe's vaccine purchase, Pfizer CEO Albert Bourla pulls out of committee hearing
Fierce Pharma
Mon, 10/3/22 - 11:39 pm
Pfizer
Albert Bourla
Pharma CEOs
COVID-19
Europe
vaccines
Kinarus stops midphase study in hospitalized COVID-19 patients early, adding to long list of failed trials
Fierce Biotech
Fri, 09/30/22 - 10:55 am
Kinarus Therapeutics
COVID-19
clinical trials
KIN001
Study identifies Covid-19 patients with mutations indicating remdesivir resistance
Endpoints
Wed, 09/28/22 - 10:27 pm
Gilead Sciences
remdesivir
COVID-19
FDA narrows EUAs for Covid-19 tests, steering companies to traditional review pathways
MedCity News
Wed, 09/28/22 - 10:51 am
FDA
COVID-19
diagnostics
Emergency Use Authorization
Hospital procedures have remained steady since H2 in boost for medtechs, survey finds
Medtech Dive
Tue, 09/27/22 - 10:31 am
hospitals
Medtech
elective procedures
pandemic
COVID-19
HHS to pay for 60K doses of Eli Lilly's COVID-19 drug following its commercialization
Beckers Hospital Review
Mon, 09/26/22 - 11:29 pm
Eli Lilly
COVID-19
bebtelovimab
federal contracts
HHS
Valneva actively discussing second-generation COVID-19 vaccine with prospective partner
PM Live
Mon, 09/26/22 - 11:02 am
Valneva
COVID-19
vaccines
funding
Pfizer/BioNTech seek FDA nod for new COVID boosters for children
Yahoo/Reuters
Mon, 09/26/22 - 10:39 am
Pfizer
BioNTech
COVID-19
FDA
vaccines
pediatric
boosters
Moderna seeks FDA nod for Omicron-targeted COVID shot for adolescents, younger kids
Yahoo/Reuters
Sun, 09/25/22 - 02:31 pm
Moderna Therapeutics
COVID-19
FDA
boosters
pediatric
vaccines
Pfizer whittles down US donation deal as global COVID-19 vaccine demand slumps
Fierce Pharma
Sun, 09/25/22 - 02:11 pm
Pfizer
vaccines
COVID-19
Pfizer to supply 6 million Paxlovid treatments to Global Fund
Axios
Thu, 09/22/22 - 10:30 am
Pfizer
Paxlovid
COVID-19
Global Fund
Clover touts phase 3 omicron data as wait for COVID-19 vaccine approvals drags on
Fierce Biotech
Tue, 09/20/22 - 10:24 am
Clover BioPharmaceuticals
COVID-19
vaccines
boosters
clinical trials
Why Novavax and Johnson & Johnson Stocks Slipped Monday
Motley Fool
Mon, 09/19/22 - 10:00 pm
JNJ
Novavax
vaccines
Joe Biden
COVID-19
BioNTech's COVID vaccine sales are poised to slip, but the shot will remain a 'cash cow' in the long term: analysts
Fierce Pharma
Mon, 09/19/22 - 09:55 pm
Pfizer
BioNTech
vaccines
COVID-19
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
…
next ›
last »